Composition and methods for the management of hyperproliferative dermatological conditions
| Filling date | : | August 02, 2004 |
| Issue date | : | September 01, 2009 |
| Inventors | : | Muhammed Majeed, Subbalakshmi Prakash |
| Assignee | : | Sami Labs Limited |
Abstract: The invention describes compositions and methods for the management of hyperproliferative skin conditions such as psoriasis. The preferential composition contains a natural leukotriene inhibitor selected from Boswellia serrata gum resin, its extractives, isolates or derivatives in combination with a bioavailable organic selenium nutritional supplement. These compositions are administered orally and topically to the individual human or animal in need of treatment at optimal levels to manifest the desired benefits, with no untoward side effects.
Composition and methods for the management of hyperproliferative dermatological conditions
| Filling date | : | October 14, 2004 |
| Issue date | : | March 02, 2006 |
| Inventors | : | Muhammed Majeed, Subbalakshmi Prakash |
| Assignee | : | Sami Labs Limited |
Abstract: The invention describes compositions and methods for the management of hyperproIiferative skin conditions such as psoriasis. The preferential composition contains a natural leukotriene inhibitor selected from Boswellia serrata gum resin, its extractives, isolates or derivatives in combination with a bioavailable organic selenium nutritional supplement. These compositions are administered orally and topically to the individual human or animal in need of treatment at optimal levels to manifest the desired benefits, with no untoward side effects.
Composition for down-regulating pro-inflammatory markers
| Filling date | : | February 28, 2011 |
| Issue date | : | October 10, 2016 |
| Inventors | : | Muhammed Majeed, Sarang Bani, Beena Bhat, Anjali Pandey |
| Assignee | : | Sami Labs Limited |
Abstract: The present invention provides a composition for down-regulating pro-inflammatory markers. The composition comprises boswellic acid fraction and polysaccharide fraction obtained from Boswellia species at specific concentrations showing enhancement in their activity as compared to boswellic acid fraction and the polysaccharide fraction alone. The invention further comprises the use of polysaccharide fraction individually or in combination with boswellic acid fraction for the inhibition of PGE2.
Composition comprising boswellic acid for downregulating/inhibiting pro-inflammatory markers
| Filling date | : | February 28, 2011 |
| Issue date | : | September 05, 2017 |
| Inventors | : | Muhammed Majeed, Sarang Bani, Beena Bhat, Anjali Pandey |
| Assignee | : | Sami Labs Limited |
Abstract: The present invention provides a composition for down-regulating pro-inflammatory markers. The composition comprises boswellic acid fraction and polysaccharide fraction obtained from Boswellia species at specific concentrations showing enhancement in their activity as compared to boswellic acid fraction and the polysaccharide fraction alone. The invention further comprises the use of polysaccharide fraction individually or in combination with boswellic acid fraction for the inhibition of PGE2.
Composition and methods for the management of hyperproliferative dermatological conditions
| Filling date | : | October 14, 2004 |
| Issue date | : | November 07, 2012 |
| Inventors | : | Muhammed Majeed, Subbalakshmi Prakash |
| Assignee | : | Sami Labs Limited |
Use of a composition for down-regulating/inhibiting PGE2
| Filling date | : | September 01, 2010 |
| Issue date | : | February 28, 2012 |
| Inventors | : | Mohammed Majid (Мухаммед Маджид), Angali Pandey (Анджали Пандей), Sarang Bani (Саранг Бани) |
| Assignee | : | Sami Labs Limited |
Abstract: The present invention provides the use of a composition for pro-inflammatory markers. The composition comprising polysaccharide fraction obtained from Boswellia species for down-regulating/inhibiting PGE2
Composition and methods for the management of hyperproliferative dermatological conditions
| Filling date | : | October 14, 2004 |
| Issue date | : | May 01, 2013 |
| Inventors | : | Muhammed Majeed, Subbalakshmi Prakash |
| Assignee | : | Sami Labs Limited |
A process of preparing a synergistic composition for treating hyperproliferative dermatological conditions
| Filling date | : | January 31, 2007 |
| Issue date | : | March 02, 2010 |
| Inventors | : | Muhammed Majeed, Subbalakshmi Prakash |
| Assignee | : | Sami Labs Limited |
Abstract: The present invention relates to a process of preparing a synergistic composition for treating hyperproliferative dermatological conditions through oral and/or topical administration, said process comprising steps of (a) obtaining Boswellia gum extract containing boswellic acids of concentration ranging between 50 mg to 500mg; (b) obtaining selenium of concentration ranging between 10 mg to 200 mg; (c) mixing the Boswellia gum extract of step (a) with selenium of step (b), optionally along with pharmaceutically acceptable excipients; and (d) obtaining the synergistic composition for treatment of hyperproliferative dermatological conditions.
Composition and methods for the management of hyper-proliferative dermatological conditions
| Filling date | : | October 14, 2004 |
| Issue date | : | August 29, 2011 |
| Inventors | : | Muhammed Majeed, Subbalakshmi Prakash |
| Assignee | : | Sabinsa Japan |
Composition and methods for the management of hyper-proliferative dermatological conditions
| Filling date | : | October 14, 2004 |
| Issue date | : | February 11, 2010 |
| Inventors | : | Muhammed Majeed, Subbalakshmi Prakash |
| Assignee | : | Sami Labs Limited |
Composition and methods for the management of hyper-proliferative dermatological conditions
| Filling date | : | October 14, 2004 |
| Issue date | : | September 10, 2009 |
| Inventors | : | Muhammed Majeed, Subbalakshmi Prakash |
| Assignee | : | Sami Labs Limited |
Composition and methods for the management of hyper-proliferative dermatological conditions
| Filling date | : | October 14, 2004 |
| Issue date | : | November 28, 2007 |
| Inventors | : | Muhammed Majeed, Subbalakshmi Prakash |
| Assignee | : | Sami Labs Limited |